Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dalian Zhen-Ao Bio-Tech is a prominent Chinese biotechnology firm specializing in the industrial-scale production of nucleotides, nucleosides, and nucleic acids. As a core subsidiary of the Zhen-Ao Group, the company operates one of the largest fermentation and extraction facilities globally for 5'-nucleotides, which are essential components in infant formula and pharmaceutical synthesis. Their product portfolio includes adenosine, cytidine, guanosine, and uridine monophosphates, as well as high-purity RNA and DNA extracts. The company serves a global market, providing raw materials for the healthcare, food, and cosmetic industries under strict quality standards including GMP and ISO certifications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dalian Zhen Ao Bio Tech.